EUCTR2012-000454-58-BE进行中(未招募)不适用
Prospective, monocentre phase I study of sequential infusion of Y90-labeled microspheres and Mitomycine C in patients with chemorefractory liver metastases from breast carcinoma
niversity Hospitals Leuven0 个研究点开始时间: 2012年3月22日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Histologically confirmed diagnosis of breast cancer
- •Radiological evidence of liver metastases
- •Liver-only or liver predominant disease
- •Progressive under (multi-line) systemic chemotherapy
- •Progressive under hormonotherapy for hor+ patients.
- •Patients scheduled for mitomycine chemoinfusion
- •Liver/lung shunt < 20% as determined by the Tc99-scan
- •Age older than 18 years
- •Karnovski >=70
- •Written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 5
排除标准
- •. Karnovsky < 70
- •. Biochemical evidence of severe haematological toxicity and liver function test disturbances (Bilirubine > 1.5; AST/ALT > 2.5 fold normal range; Creatinine > 1.2 upper normal limit; GFR (glomerular filtration rate) < 60)
- •. Neutrophiles < 1000/ml
- •. Thrombocytes < 100.000
- •. Liver/lung shunt > 20% as determined by the Tc99-scan
- •. Allergy to contrast media
- •. Intake of oral anticoagulation
研究者
相似试验
进行中(未招募)
1 期
Sequential treatment with Gemcitabine/Nab-Paclitaxel then Folfirinox followed by MRI-guided radiotherapy in patients with locally advanced adenocarcinoma of the pancreasEUCTR2020-002517-18-FRInstitut régional du cancer de Montpellier (ICM)103
进行中(未招募)
1 期
Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic CancerCTIS2024-515344-23-00Institut Regional Du Cancer De Montpellier103
已完成
不适用
Phase II Randomized Comparative Study of Sequential Alternating Therapy with Interferon and Molecular-Targeted Drug for Advanced Renal Cell CarcinomaAdvanced Renal Cell CarcinomaJPRN-UMIN000001994Osaka Urological Oncology Research Group100
进行中(未招募)
不适用
A study in patients with Tcell lymphoma to look at the effects of a new treatmentPatients with previously undiagnosed peripheral T-cell lymphoma who have achieved an objective response following initial treatment with CHOP based chemotherapyMedDRA version: 14.1Level: PTClassification code 10034623Term: Peripheral T-cell lymphoma unspecifiedSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-022230-81-ITALLOS549
已完成
不适用
Correlative observational study of phase 1 study of RK-163 pulsed human autologous CD14-positive cells (RK-CD14MO) for patients with advanced or relapsed solid tumorAdvanced or relapsed solid tumorJPRN-UMIN000032306Keio University Hospital18
